TFGT
SAGE

TS Financial Group (TSFG)’s Sage Therapeutics SAGE Stock Holding History

TS Financial Group (TSFG)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75
Closed -$1K – 890
2025
Q2 		$1K Hold
75
– – ﹤0.01% 785
2025
Q1 		$1K Buy
+75
New +$549 ﹤0.01% 780

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TS Financial Group (TSFG)'s SAGE Position: Q3 2025 in Review

TS Financial Group (TSFG) sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 75 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $1K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • TS Financial Group (TSFG) reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 75 Sage Therapeutics shares in Q3 2025, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • TS Financial Group (TSFG)'s Sage Therapeutics position peaked at $1K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q3 2025, filed 4 Nov 2025.